{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:51:40Z","timestamp":1783511500258,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2018.12.016","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T19:58:52Z","timestamp":1546545532000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015\u20132016"],"prefix":"10.1016","volume":"17","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.12.016_bib0005","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00143-10","article-title":"Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy","volume":"54","author":"Tumbarello","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.016_bib0010","first-page":"411","article-title":"Analysis of resistance tendency of bloodstream-infecting pathogens in China","volume":"36","author":"Yuan","year":"2013","journal-title":"Chin J Tuberc Respir Dis"},{"key":"10.1016\/j.jgar.2018.12.016_bib0015","first-page":"103","article-title":"Antimicrobial susceptibility of Enterobacteriaceae and Haemophilus: results from China Antimicrobial Resistance Surveillance Trial Program, 2013-2014","volume":"39","author":"Yun","year":"2016","journal-title":"Chin J Lab Med"},{"key":"10.1016\/j.jgar.2018.12.016_bib0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","article-title":"Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014","volume":"85","author":"Lob","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.016_bib0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/AAC.47.2.790-793.2003","article-title":"Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China","volume":"47","author":"Wang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.016_bib0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3343\/kjlm.2011.31.4.257","article-title":"Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae","volume":"31","author":"Jeong","year":"2011","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.jgar.2018.12.016_bib0035","first-page":"130","article-title":"Antimicrobial susceptibility of nonfermenting gram-negative bacteria: results from China Antimicrobial Resistance Surveillance Trial Program, 2013-2014","volume":"39","author":"Yun","year":"2016","journal-title":"Chin J Lab Med"},{"key":"10.1016\/j.jgar.2018.12.016_bib0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.12.016_bib0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijantimicag.2016.01.015","article-title":"Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii","volume":"47","author":"Lob","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.12.016_bib0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0366-6999.201601","article-title":"Trends in Drug Resistance of Acinetobacter baumannii over a 10-year Period: Nationwide Data from the China Surveillance of Antimicrobial Resistance Program","volume":"130","author":"Gao","year":"2017","journal-title":"Chin Med J"},{"key":"10.1016\/j.jgar.2018.12.016_bib0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13756-016-0162-z","article-title":"Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014","volume":"6","author":"Ahmed","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jgar.2018.12.016_bib0060","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/cid\/cix640","article-title":"Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014","volume":"65","author":"Klein","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.016_bib0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijantimicag.2016.04.021","article-title":"Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014)","volume":"48","author":"Sader","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.12.016_bib0070","first-page":"120","article-title":"Antimicrobial susceptibility of gram-positive organisms: results from China Antimicrobial Resistance Surveillance Trial Program, 2013-2014","volume":"39","author":"Yun","year":"2016","journal-title":"Chin J Lab Med"},{"key":"10.1016\/j.jgar.2018.12.016_bib0075","first-page":"251","article-title":"Antimicrobial susceptibility surveillance of gram-positive bacterial from Ministry of Health National Antimicrobial Resistant Investigation Net (Mohnarin) 2011-2012","volume":"30","author":"Yun","year":"2014","journal-title":"Chin J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2018.12.016_bib0080","first-page":"61","article-title":"Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)","author":"Pfaller","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.016_bib0085","first-page":"278","article-title":"Mohnarin report of 2011-2012: surveillance for resistance of bacteria causing bloodstream infections","volume":"30","author":"Yuan","year":"2014","journal-title":"Chin J Clin Pharmacol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T20:47:01Z","timestamp":1560890821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518302601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":17,"alternative-id":["S2213716518302601"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.016","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015\u20132016","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}